Labshake search
Citations for Bio X Cell :
251 - 267 of 267 citations for IL 4 Human CHO since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... Cells were washed in FACS buffer followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing 1:100 anti-CD16/32 (Fc block; BioXCell) to block non-specific binding ...
-
bioRxiv - Immunology 2021Quote: ... Cells (4 × 108 per ml) were incubated on ice for 10 min with anti-CD16/32 ‘Fc block’ (2.4G2; Bio X Cell) prior to staining in the dark for 30 min on ice with fluorophore or biotin-labeled monoclonal antibodies prepared in brilliant stain buffer (BD Biosciences ...
-
bioRxiv - Synthetic Biology 2019Quote: Antibodies used for in vivo experiments include: anti-mouse PD-L1 (BioXCell cat: BE0101and anti-mouse CTLA-4 (BioXCell cat: BE0164). Pre-conjugated primary antibodies used for flow cytometry and microscopy include ...
-
bioRxiv - Cancer Biology 2020Quote: ... were used for checkpoint blocking on tumors as well as T cells: functional grade PD-L1 (29E.2A3) and CTLA-4 (BN13) (Bioxcell, USA). In brief ...
-
bioRxiv - Immunology 2023Quote: ... cells were stained in the dark for 15 min at 4°C with fluorochrome-conjugated antibodies in PBS containing anti-CD16/CD32 (2.4G2; BioXcell or BioLegend). Cells were washed and ...
-
bioRxiv - Immunology 2023Quote: ... LCMV-NP (self-conjugated to AF488 using Thermo Fisher AF488 labeling kit per manufacturer’s instructions, BioXcell, 1:50, clone VL-4).
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2023Quote: NK cells were depleted from C57BL/6 mice starting at 3-4 weeks of age by intraperitoneal injection of 200 µg of anti-NK1.1 mAb (clone PK136, Bio X Cell) every 5 days for 3 weeks.
-
bioRxiv - Immunology 2024Quote: ... Cells were activated by TCR stimulation using plate-bound human anti-CD3 and soluble CD28 (clone OKT-3 and clone 9.3 Bio X Cell, respectively, 5 μg/mL of each) for 3 days ...
-
bioRxiv - Immunology 2019Quote: ... For Th2 induction 1×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell) and αCD28 (10 μg mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... 2 to 3×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell), αCD28 (1 μg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BXC-BE0131) antibodies or isotype controls (BXC-BE0094 and BXC-BP0087) twice per week (10 mg/kg each, Bio X cell). Therapies started at day 70 for all mice ...
-
bioRxiv - Cancer Biology 2023Quote: ... were injected intraperitoneally with monoclonal antibodies against PD-1 (RMP1-14, 250 μg per dose) and CLTA-4 (9D9, 100 μg per dose) (BioXCell, Lebanon, NH) in sterile PBS or a control PBS solution (25) ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Cancer Biology 2023Quote: ... with each group receiving either PBS or RGS (100 mg/kg/day) or CTLA-4 mAb (10 mg/kg, twice a week; Bio X Cell, BE0032) or corresponding isotype (Bio X Cell ...
-
bioRxiv - Cancer Biology 2021Quote: Six month old KRC mice were enrolled onto the anti CTLA-4 treatment trial and treated with either anti-CTLA4 antibody (clone 9H10; Bio X Cell, Lebanon, NH) or InVivoPlus Syrian hamster IgG isotype control antibody (Cat# BP0087 ...
-
bioRxiv - Immunology 2021Quote: ... The following antibodies were used for in vivo blocking experiments: anti-LFA-1α (M17/4) and anti-Mac-1 (M1/70) (both from Bio X Cell, West Lebanon, NH). The following antibodies or reagents were used for in vivo cell depletion ...